The Role of Probiotic Cultures in the Control of Gastrointestinal Health
Top Cited Papers
Open Access
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Journal of Nutrition
- Vol. 130 (2) , 396S-402S
- https://doi.org/10.1093/jn/130.2.396s
Abstract
The use of probiotics to enhance intestinal health has been proposed for many years. Probiotics are traditionally defined as viable microorganisms that have a beneficial effect in the prevention and treatment of specific pathologic conditions when they are ingested. There is a relatively large volume of literature that supports the use of probiotics to prevent or treat intestinal disorders. However, the scientific basis of probiotic use has been firmly established only recently, and sound clinical studies have begun to be published. Currently, the best-studied probiotics are the lactic acid bacteria, particularly Lactobacillus sp. and Bifidobacterium sp. However, other organisms used as probiotics in humans include Escherichia coli, Streptococcus sp., Enterococcus sp., Bacteroides sp., Bacillus sp., Propionibacterium sp. and various fungi. Some probiotic preparations contain mixtures of more than one bacterial strain. Probiotics have been examined for their effectiveness in the prevention and treatment of a diverse spectrum of gastrointestinal disorders such as antibiotic-associated diarrhea (including Clostridium difficile–associated intestinal disease), infectious bacterial and viral diarrhea (including diarrhea caused by rotavirus, Shigella, Salmonella, enterotoxigenic E. coli, Vibrio cholerae and human immunodeficiency virus/acquired immunodeficiency disorder, enteral feeding diarrhea, Helicobacter pylori gastroenteritis, sucrase maltase deficiency, inflammatory bowel disease, irritable bowel syndrome, small bowel bacterial overgrowth and lactose intolerance. Probiotics have been found to inhibit intestinal bacterial enzymes involved in the synthesis of colonic carcinogens. There are many mechanisms by which probiotics enhance intestinal health, including stimulation of immunity, competition for limited nutrients, inhibition of epithelial and mucosal adherence, inhibition of epithelial invasion and production of antimicrobial substances. Probiotics represent an exciting prophylactic and therapeutic advance, although additional investigations must be undertaken before their role in intestinal health can be delineated clearly.Keywords
This publication has 68 references indexed in Scilit:
- The potential of Lactobacillus as a carrier for oral immunization: Development and preliminary characterization of vector systems for targeted delivery of antigensJournal of Biotechnology, 1996
- In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteriaJournal of Applied Bacteriology, 1995
- Oral bacteriotherapy for viral gastroenteritisDigestive Diseases and Sciences, 1994
- Survival ofLactobacillus species (strain GG) in human gastrointestinal tractDigestive Diseases and Sciences, 1992
- Restorative Proctocolectomy–The Pouch Operation: Good or Bad?Scandinavian Journal of Gastroenterology, 1992
- Tube Feeding‐Related Diarrhea in Acutely III PatientsJournal of Parenteral and Enteral Nutrition, 1991
- Inflammation in ileal reservoirs: 'pouchitis'.Gut, 1990
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989
- Enzyme-Substitution Therapy with the YeastSaccharomyces cerevisiaein Congenital Sucrase-Isomaltase DeficiencyNew England Journal of Medicine, 1987
- Lactobacillus acidophilus (Enpac) in Treatment of Hepatic EncephalopathyBMJ, 1966